52-Week High Companies: International Business Machines Corp., Toyota Motor Corp., AstraZeneca PLC, McDonald's Corp., and BristolMyers Squibb Company

52-Week High Companies: IBM, TM, AZN, MCD, BMY

Author's Avatar
Jan 04, 2010
According to GuruFocus updates, these Guru stocks have reached their 52-Week Highs: International Business Machines Corp. (IBM, Financial), Toyota Motor Corp. (TM, Financial), AstraZeneca PLC (AZN, Financial), McDonald's Corp. (MCD, Financial), and BristolMyers Squibb Company (BMY, Financial).


International Business Machines Corp (IBM) Reached the 52-Week High of $130.9


International Business Machines Corp. uses advanced information technology to provide customer solutions. International Business Machines Corp has a market cap of $171.95 billion; its shares were traded at around $130.9 with a P/E ratio of 13.5 and P/S ratio of 1.7. The dividend yield of International Business Machines Corp stocks is 1.7%. International Business Machines Corp had an annual average earning growth of 4.9% over the past 10 years.


Add a paragraph here!


Try company press releases: Company Website to find headlines. Or Please check headlines and describe the current events of the company. Use this Yahoo link to find headlines.


International Business Machines Corp. is in the portfolios of Bill Miller of Legg Mason Value Trust, David Williams of Columbia Value and Restructuring Fund, Jeremy Grantham of GMO LLC, Ronald Muhlenkamp of Muhlenkamp Fund, Ken Heebner of CAPITAL GROWTH MANAGEMENT LP, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, John Hussman of Hussman Economtrics Advisors, Inc., Robert Olstein of Olstein Financial Alert Fund, John Buckingham of Al Frank Asset Management, Inc., Irving Kahn of Kahn Brothers & Company Inc., Bruce Kovner of Caxton Associates, Bill Frels of MAIRS & POWER INC, Mark Hillman of Hillman Capital Management, Private Capital of Private Capital Management, Louis Moore Bacon of Moore Capital Management, LP, John Rogers of ARIEL CAPITAL MANAGEMENT LLC, Paul Tudor Jones of The Tudor Group, Tom Gayner of Markel Gayner Asset Management Corp, Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, Tom Russo of Gardner Russo & Gardner, Dodge & Cox, George Soros of Soros Fund Management LLC, Richard Snow of Snow Capital Management, L.P., Chris Davis of Davis Selected Advisers, Murray Stahl of Horizon Asset Management, Kenneth Fisher of Fisher Asset Management, LLC, and John Keeley of Keeley Fund Management.


In November, Sell:: Chairman, Pres., and CEO Samuel J Palmisano sold 1,700 shares of IBM stock on and the price has increased over 6% since. Sell:: Sr. VP and CFO Mark Loughridge sold 37,269 shares in October. Sell:: Senior Vice President Timothy S Shaughnessy, Sell:: VP, Controller James J Kavanaugh, Sell:: Senior Vice President John E Kelly III, Sell:: Senior Vice President Rodney C Adkins and Sell:: Senior Vice President Virginia M Rometty sold shares in November.


Toyota Motor Corp. (TM) Reached the 52-Week High of $84.16


Toyota Motor Corporation produces, sells, leases, and repairs passenger cars, trucks, buses, boats, airplanes and other products in Japan and most foreign countries. The Company is also involved in the businesses of real estate, civil engineering, insurance and so on. Toyota Motor Corp. has a market cap of $131.96 billion; its shares were traded at around $84.16 with and P/S ratio of 0.6. The dividend yield of Toyota Motor Corp. stocks is 1.3%. Toyota Motor Corp. had an annual average earning growth of 17.4% over the past 10 years.


On December 1, Toyota Motor Sales U.S.A., Inc., reported November sales of 133,700 vehicles, an increase of 11.5 percent over last November, on a daily selling rate basis. The Toyota Division posted November sales of 115,200 units, an increase of 9.8 percent over the same period last year. The Lexus Division reported November sales of 18,500 units, an increase of 24 percent over the year-ago month.


Toyota Motor Corp. is in the portfolios of Charles Brandes of Brandes Investment, John Rogers of ARIEL CAPITAL MANAGEMENT LLC, John Buckingham of Al Frank Asset Management, Inc., Paul Tudor Jones of The Tudor Group, and Bruce Kovner of Caxton Associates.


AstraZeneca PLC (AZN) Reached the 52-Week High of $46.94[/b]


AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. Astrazeneca PLC has a market cap of $68.04 billion; its shares were traded at around $46.94 with a P/E ratio of 8.1 and P/S ratio of 2.1. The dividend yield of Astrazeneca Plc stocks is 4.5%. Astrazeneca Plc had an annual average earning growth of 12.2% over the past 10 years. GuruFocus rated Astrazeneca Plc the business predictability rank of 2-star.


AstraZeneca PLC is in the portfolios of Edward Owens of Vanguard Health Care Fund, John Hussman of Hussman Economtrics Advisors, Inc., Charles Brandes of Brandes Investment, Paul Tudor Jones of The Tudor Group, Bruce Kovner of Caxton Associates, Kenneth Fisher of Fisher Asset Management, LLC, and John Buckingham of Al Frank Asset Management, Inc.



[b]McDonald's Corp. (MCD) Reached the 52-Week High of $62.44
[/b]


McDonald's Corporation develops, operates, franchises and services a worldwide system of restaurants that prepare, assemble, package and sell a limited menu of value-priced foods. The company operates primarily in the quick-service hamburger restaurant business. All restaurants are operated by the company or, under the terms of franchise arrangements, by franchisees who are independent third parties, or by affiliates operating under joint-venture agreements between the company and local business people. McDonald's Corp. has a market cap of $67.38 billion; its shares were traded at around $62.44 with a P/E ratio of 16.3 and P/S ratio of 2.9. The dividend yield of Mcdonald's Corp. stocks is 3.5%. Mcdonald's Corp. had an annual average earning growth of 7.2% over the past 10 years.


On Oct 22, McDonald's Corporation today announced strong results for the third quarter ended September 30, 2009. Global comparable sales increased 3.8% with the U.S. up 2.5%, Europe up 5.8% and Asia/Pacific, Middle East and Africa up 2.2% Consolidated operating income increased 6% (11% in constant currencies)over the prior year.


McDonald’s Corp. is in the portfolios of Bill Ackman of Pershing Square Capital Management, L.P., Steve Mandel of Lone Pine Capital, Bill Gates of Bill & Melinda Gates Foundation Trust, Diamond Hill Capital of Diamond Hill Capital Management Inc, Robert Olstein of Olstein Financial Alert Fund, Bill Nygren of Oak Mark Fund, David Winters of Wintergreen Advisors, Chase Coleman of TIGER GLOBAL MANAGEMENT LLC, Jeremy Grantham of GMO LLC, HOTCHKIS & WILEY of HOTCHKIS & WILEY Capital Management LLC, Tom Gayner of Markel Gayner Asset Management Corp, John Buckingham of Al Frank Asset Management, Inc., Paul Tudor Jones of The Tudor Group, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, Stanley Druckenmiller of Duquesne Capital Management, LLC, Tom Russo of Gardner Russo & Gardner, Ron Baron of Baron Funds, Dodge & Cox, Bill Frels of MAIRS & POWER INC, Richard Aster Jr of Meridian Fund, Murray Stahl of Horizon Asset Management, and George Soros of Soros Fund Management LLC.


[b]Buy:
: Director John W Jr Rogers bought 500 shares of MCD stock in August; the price has increased by 13% since. Sell:: President and COO Ralph Alvarez and Sell:: Director Jeanne P Jackson sold shares in December; Sell:: President, McDonald's USA Donald Thompson and Sell:: President, McDonald's APMEA Timothy J Fenton sold shares in November.


BristolMyers Squibb Company (BMY) Reached the 52-Week High of $25.25


Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions. BristolMyers Squibb Company has a market cap of $50.02 billion; its shares were traded at around $25.25 with a P/E ratio of 12.5 and P/S ratio of 2.5. The dividend yield of Bristolmyers Squibb Company stocks is 4.9%.


On October 22, Bristol-Myers Squibb posted third quarter 2009 net sales from continuing operations of $5.5 billion, an increase of 4%, or 7% excluding foreign exchange impact, compared to the same period in 2008. Gross profit improved to 71.5% of net sales in the third quarter 2009 compared to 68.9% in 2008. The improvement was driven by higher biopharmaceutical average prices, realized manufacturing efficiencies, including savings from continuous improvement efforts, favorable foreign exchange impact and favorable worldwide product mix.


BristolMyers Squibb Company is in the portfolios of Irving Kahn of Kahn Brothers & Company Inc., Edward Owens of Vanguard Health Care Fund, Bill Nygren of Oak Mark Fund, Charles Brandes of Brandes Investment, HOTCHKIS & WILEY of HOTCHKIS & WILEY Capital Management LLC, David Williams of Columbia Value and Restructuring Fund, Brian Rogers of T Rowe Price Equity Income Fund, John Buckingham of Al Frank Asset Management, Inc., Jeremy Grantham of GMO LLC, Bill Frels of MAIRS & POWER INC, Louis Moore Bacon of Moore Capital Management, LP, NWQ Managers of NWQ Investment Management Co, Dodge & Cox, Murray Stahl of Horizon Asset Management, Prem Watsa of Fairfax Financial Holdings, Inc., Kenneth Fisher of Fisher Asset Management, LLC, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, and Bruce Berkowitz of Fairholme Capital Management.


Go here for the complete list of 52-Week Highs.


Become a Premium Member to See This: (Free Trial):